meth-SemiCancer2: a cancer subtyping framework leveraging domain adaptation with contrastive learning for batch effect correction in DNA methylation profiles.
The online reader was unable to display this document directly. This may occur if the repository host is temporarily unreachable, or if security restrictions (CORS) prevent embedded viewing.